Ranitidine HCl price index

Ranitidine HCl price December 2025 and outlook (see chart below)

• India:US$18.89/KG, -0.1% down

Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.

Ranitidine HCl price index

This post is a summary of the Ranitidine HCl price developments. The price developments of Ranitidine HCl are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Ranitidine HCl price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.

The outlook for Ranitidine HCl prices is generated from different inputs including:

• Very recent price developments of immediate cost drivers of Ranitidine HCl prices
• Recent price developments of underlying feedstocks which drive the price of Ranitidine HCl
• Market futures for both cost drives and feedstocks of Ranitidine HCl prices
• Adjustment of current supply/demand imbalances in the Ranitidine HCl market
• Longer term trends in likely demand conditions

What is Ranitidine HCl and what is it used for

Ranitidine HCl (ranitidine hydrochloride) is a histamine‑2 (H₂) receptor antagonist that works by blocking H₂ receptors on the stomach’s parietal cells and thereby reducing gastric acid secretion. It has historically been used to treat and prevent stomach and intestinal ulcers, gastroesophageal reflux disease (GERD), conditions in which the stomach produces too much acid (such as Zollinger–Ellison syndrome), and heartburn associated with acid indigestion. In many jurisdictions it has been withdrawn or limited due to concerns about impurities (e.g., N‑nitrosodimethylamine, NDMA) in some ranitidine products.

How is Ranitidine HCl

Ranitidine HCl is formulated as the hydrochloride salt of ranitidine to enhance its solubility and stability. It is available in tablets, oral syrup, effervescent formulations and injection in certain regions. It is taken orally (or administered by injection where approved) and is absorbed, then functions by antagonising H₂ receptors on gastric parietal cells to reduce acid secretion. Because of the safety concerns mentioned above (NDMA contamination), many markets have either removed ranitidine or required reformulated versions with safer impurity profiles.

How large is the global market for Ranitidine HCl and where is it produced

The global market for ranitidine (including ranitidine HCl) is somewhat fragmented and subject to regulatory impacts. One report values the global ranitidine market at approximately **USD 2.5 billion in 2023**, with a projected rise to around USD 3.8 billion by 2032. Another source estimates an earlier global market size of about USD 3.84 billion in 2024, with projected growth to USD 4.18 billion by 2031. Other analyses show smaller numbers (for example ~USD 412 million in 2025) reflecting different segmentation or impacted markets. Production of ranitidine HCl and its active pharmaceutical ingredient (API) is concentrated primarily in Asia, particularly in India and China, with additional manufacturing and finishing in other countries. API supplier listings and manufacturing directories list India and China as major origins. The drug is marketed globally under many generic and brand names by companies that operate manufacturing in these regions.

Note: This summary provides an overview only and not prescribing or regulatory advice.